DaHee Han, PharmD

Most Recent Articles by DaHee Han, PharmD

Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation

Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation

By

NeuroRx announced that the FDA has granted Breakthrough Therapy designation to NRX-101 for the treatment of severe bipolar depression with acute suicidal ideation.

FDA Panel Votes on Postpartum Depression Treatment Zulresso

FDA Panel Votes on Postpartum Depression Treatment Zulresso

By

If approved, Zulresso would be the first drug approve for the treatment of postpartum depression.

FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers

FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers

By

The 23andMe Personal Genome Service Pharmacogenetic Reports test can detect 33 variants for multiple genes, corresponding to more than 50 commonly prescribed medications and over-the-counter products.

New Blood Test Identifies Metabolic Subtypes Linked to Autism Spectrum Disorder

New Blood Test Identifies Metabolic Subtypes Linked to Autism Spectrum Disorder

By

NeuroPointDX announced the availability of the NPDX AA test, the first objective blood test that identifies metabolic subtypes associated with ASD in children as young as 18 months old.

Certain Lots of Quillivant XR May Potentially Have Quality/Efficacy Issues

Certain Lots of Quillivant XR May Potentially Have Quality/Efficacy Issues

By

Quillivant XR, a central nervous system stimulant, is indicated to treat ADHD in patients aged 6 years and older.

More Articles by DaHee Han, PharmD

Sign Up for Free e-newsletters